Criminals are targeting pharmacies and stealing weight-loss medication in a country with body image insecurities and where ...
Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...
An abrupt aversion to sex is a common, albeit lesser-known, complication of taking GLP-1 medications, such as Mounjaro, ...
A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic and Wegovy, falsely claim they are FDA-approved.
Injections like Wegovy have been hailed 'wonder-drugs' for their ability to help with a number of health conditions ...
A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and vision loss.
Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...
Organic Payment Gateways, a leading provider of specialized payment solutions, proudly announces the launch of its easily integrated payment gateway and merchant account program. This program is ...
Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.
MIAMI - Drugs like Ozempic, Wegovy and Mounjaro have transformed the weight loss industry, becoming household names seemingly overnight. Touted as game-changers, these medications not only help ...
Hannah's doctor prescribed Saxenda - part of a group of drugs known as GLP-1 receptor agonists - and she began the daily injections. Drugs like Ozempic, Mounjaro and Saxenda have swept the globe ...
Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ingredient, they are approved for different purposes. Ozempic is primarily ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results